Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases

by Arun J. Sanyal, Lei Ling, Ulrich Beuers, Alex M. DePaoli, Hsiao D. Lieu, Stephen A. Harrison, Gideon M. Hirschfield
Published 2021-06-01